EP2536730
Pýrrólópýrímídínefnasambönd sem CDK4/6 hemlar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
17.2.2011EP published:
8.7.2015EP application number:
11707115.9
EP translation filed:
21.9.2015Grant published:
15.10.2015EPO information:
European Patent Register
Max expiry date:
16.2.2031Expiry date:
16.2.2017
Title:
PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6
Timeline
Today
17.2.2011EP application
8.7.2015EP Publication
21.9.2015Translation submitted
15.10.2015Registration published
16.2.2017Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
BRAIN, Christopher, ThomasAddress:
CambridgeMassachusetts, US
Name:
CHO, Young ShinAddress:
CambridgeMassachusetts, US
Name:
GIRALDES, John, WilliamAddress:
Cambridge, MA, US
Name:
LAGU, BharatAddress:
CambridgeMassachusetts, US
Name:
LEVELL, JulianAddress:
CambridgeMassachusetts, US
Name:
LUZZIO, MichaelAddress:
CambridgeMassachusetts, US
Name:
PEREZ, Lawrence, BlasAddress:
CambridgeMassachusetts, US
Name:
WANG, YapingAddress:
BoxboroughMassachusetts, US
Name:
YANG, FanAddress:
CambridgeMassachusetts, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
429997 PDate:
5.1.2011Country:
US
Number:
429372 PDate:
3.1.2011Country:
US
Number:
306248 PDate:
19.2.2010Country:
US
Classification
Categories:
C07D 487/04, C07B 59/00, A61K 31/519, A61P 35/00, C07D 519/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 5.1.2016
Expires: 16.2.2017
Payer: Árnason Faktor